Study on [14C]HMPL-453（FGFR Inhibitor） in Healthy Chinese Adult Male Subjects

Study Evaluating Oral Administrations of HKI-272 in Healthy Male Subjects

NCT00550212 ·Status: COMPLETED ·Phase: PHASE1

A Clinical Study to Evaluate the Pharmacokinetics and Bioequivalence of HMPL-523 Tablets Produced by Two Different Manufacturers

NCT05318820 ·Status: COMPLETED ·Phase: EARLY_PHASE1

[¹⁴C] Hydronidone Mass Balance Study

NCT07471217 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

Human Mass Balance Study of [¹⁴C]HRS-1893

NCT07656779 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers

NCT04324424 ·Status: COMPLETED ·Phase: PHASE1

A Study of Safety and Tolerability of Multiple Doses of HRS-7535 in Obese Subjects

NCT06621316 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Long-term Efficacy and Safety of HRS-7535 Tablets in Obese Subjects

NCT06671821 ·Status: COMPLETED ·Phase: PHASE2

Pharmacokinetics, Pharmacodynamics and Safety of SHR4640 in Patients With Hepatic Impairment

NCT04305392 ·Status: UNKNOWN ·Phase: PHASE1

Phase 1 Hepatic Insufficiency Trial of Methoxyethyl Etomidate Hydrochloride

NCT06176716 ·Status: RECRUITING ·Phase: PHASE1

A Pharmacokinetic Study of VCT220 in Particicants With Hepatic Injury and Normal Hepatic Function

NCT06938529 ·Status: COMPLETED ·Phase: PHASE1

A Phase IV Study of Huazhi Rougan Granule

NCT06188611 ·Status: COMPLETED ·Phase: PHASE4

Single-Dose, Open-Label Pharmacokinetic Study of Bardoxolone Methyl in Subjects With Mild, Moderate, and Severe Hepatic Impairment and Normal Hepatic Function

NCT01563562 ·Status: COMPLETED ·Phase: PHASE1

Metabolism and Disposition of [14C] Herombopag in Chinese Healthy Human Subjects

NCT03977805 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Pharmacokinetics and Pharmacodynamics of Canagliflozin in Healthy Chinese Volunteers

NCT01707316 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating HKI-272 Administered to Healthy Subjects

NCT00366600 ·Status: COMPLETED ·Phase: PHASE1

An Open-Label Study of Aficamten for Chinese Patients With Symptomatic oHCM

NCT06116968 ·Status: COMPLETED ·Phase: PHASE3

A Trial to Investigate the Efficacy of OPC-41061 Administered at a Dose of 7.5 mg in Patients With Hepatic Edema

NCT01050530 ·Status: COMPLETED ·Phase: PHASE3

Study on Hydronidone Capsule BE

NCT04125056 ·Status: COMPLETED ·Phase: NA

Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With Hepatocirrhosis

NCT01359462 ·Status: COMPLETED ·Phase: PHASE1

QTc Assessment in a Single-Dose Study of Hydronidone Capsules

NCT07263152 ·Status: COMPLETED ·Phase: PHASE1

A Multicenter, Open-label, Dose-finding Trial of OPC-41061 to Investigate Efficacy, Pharmacokinetics, Pharmacodynamics, and Safety in Patients With Carcinomatous Edema (Phase 2)

NCT01684202 ·Status: COMPLETED ·Phase: PHASE2

Single Dose of 7.5mg Tolvaptan Phase I Clinical Trial Protocol

NCT07166783 ·Status: COMPLETED ·Phase: PHASE1

Study of the Pharmacokinetics and Safety of TPN171H Tablets in Subjects With Mild ,Moderate Hepatic Insufficiency and Normal Liver Function

NCT05185011 ·Status: COMPLETED ·Phase: PHASE1

A Dose-defining Study of OPC-41061 in Treatment of Hepatic Edema

NCT00479336 ·Status: COMPLETED ·Phase: PHASE2

Multiple Dose Effects of Hydrochlorothiazide and Isosorbide Mononitrate on Glucose Homeostasis (MK-0000-117)(Completed)

NCT00871871 ·Status: COMPLETED ·Phase: PHASE1